Infantile-Spasms-Information-Page

Infantile Spasms Information Page


What research is being done?

The NINDS supports broad and varied programs of research on epilepsy and other seizure disorders aimed at discovering new ways to prevent, diagnose, and treat these disorders.  Studies looking at the cellular, mlolecular, and genetic bases of epilepsy may lead to new therapies.  In one project, scientists are investigating whether insulin growth factor-1, which has been shown to have neuroprotective aspects in some studies, can reduce the serious side effects of vigabatrin in order to develop a new combination therapy for infantile epilepsy.
Epilepsy

×
What research is being done?

The NINDS supports broad and varied programs of research on epilepsy and other seizure disorders aimed at discovering new ways to prevent, diagnose, and treat these disorders.  Studies looking at the cellular, mlolecular, and genetic bases of epilepsy may lead to new therapies.  In one project, scientists are investigating whether insulin growth factor-1, which has been shown to have neuroprotective aspects in some studies, can reduce the serious side effects of vigabatrin in order to develop a new combination therapy for infantile epilepsy.
Epilepsy

The NINDS supports broad and varied programs of research on epilepsy and other seizure disorders aimed at discovering new ways to prevent, diagnose, and treat these disorders.  Studies looking at the cellular, mlolecular, and genetic bases of epilepsy may lead to new therapies.  In one project, scientists are investigating whether insulin growth factor-1, which has been shown to have neuroprotective aspects in some studies, can reduce the serious side effects of vigabatrin in order to develop a new combination therapy for infantile epilepsy.
Epilepsy


Definition
Definition
Treatment
Treatment
Prognosis
Prognosis
Clinical Trials
Clinical Trials
Organizations
Organizations
Publications
Publications
201 Chicago Avenue, Suite 200
Minneapolis, MN 55415
Tel: 612-928-6325
8301 Professional Place East, Suite 200
Landover, MD 20785-2353
Tel: 301-459-3700; 800-EFA-1000 (332-1000)
PO Box 365
6360 Shallowford Road
Lewisville, NC 27023
Tel: 336-946-1570
55 Kenosia Avenue
Danbury, CT 06810
Tel: 203-744-0100; Voice Mail: 800-999-NORD (6673)